GOSS Gossamer Bio Inc

In a report released today, David Hoang from SMBC Nikko downgraded Gossamer Bio (GOSS - Research Report) to a Hold, with a price target of $3.00. The company's shares closed yesterday at $2.36.According to TipRanks, Hoang is ranked #6466 out of 8067 analysts.Gossamer Bio has an analyst consensus of Moderate Buy, with a price target consensus of $11.13, representing a 371.61% upside. In a report released today, Barclays also downgraded the stock to a Hold with a $2.00 price target.See Insiders’ Hot Stocks on TipRanks >> Based on Gossamer Bio's latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $59.36 million.
https://www.tipranks.com/news/blurbs/smbc-nikko-downgrades-gossamer-bio-goss-to-a-hold?utm_source=advfn.com&utm_medium=referral